Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-09-04
2007-09-04
Carlson, Karen Cochrane (Department: 1656)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100, C435S069100, C530S350000
Reexamination Certificate
active
11042707
ABSTRACT:
The present invention relates to processes for the production of mistletoe lectin polypeptides in homologous and heterologous host systems and mistletoe lectin peptides. Further, nucleic acid molecules are provided, which encode these mistletoe lectin polypeptides, and also pharmaceutical compositions comprising mistletoe lectin nucleic acids. The present invention also relates to isolated mistletoe lectin polypeptides and pharmaceutical compositions comprising said polypeptides.
REFERENCES:
patent: 5091309 (1992-02-01), Schlesinger et al.
patent: 6271368 (2001-08-01), Lentzen et al.
patent: 0751211 (1997-01-01), None
patent: 0884388 (1998-12-01), None
patent: WO96/21458 (1996-07-01), None
patent: WO98/29540 (1998-07-01), None
Beuth et al.,Arzeim-Forsch./Drug.Res., (43) 166-169(1993).
Beuth et al.,Arzeim-Forsch./Drug.Res., (45)1240-1242(1995).
Beuth et al.,Clin. Investing, (70)658-661(1992).
Beuth et al.,In Vivo, (5)29-32(1991).
Beuth et al.,In Vivo, (7)407-410(1993).
Beuth et al.,In Vivo, (8)989-992(1994).
Beuth et al.,Med. Welt, (44)217-220(1993).
Borgnia, M. J. et al, Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a commom P-glycoprotein pharmacophore as revealed by its ATPase activity. J. Biol. Chem. vol. 271, pp. 3163-2171 (1996).
Eck, J. et al. Characterization of recombinant and plant-derived mistletoe lectin and their B-chains. Eur. J. Biochem. vol. 265, pp. 788-797, (1999).
Falconer er al.,J. Endrocrinol., (118)5-8(1988).
Gabius et al., “The Immunomodulatory Beta-Galactoside-Specific Lectin fom Mistletoe: Partial Sequence Analysis, Cell and Tissue Binding, and Impact on Intracellular Biosignalling of Monocytic Leukemia Cells”,Anticancer Research, (12:3)669-676(1992).
Hajto et al.,Cancer Res., (50)3322-3326(1990).
Harris et al., “Strategies for Targeted Gene Therapy”,Trends in Genetics, (12:10)400-405(1996).
Heiny et al.,Anticancer Res., (14)1339-1342(1994).
Huguet et al., “Complete Amino Acid Sequence if the A-Chain of Mistletoe Lectin I”,FEBS Letters, (399)153-157(1996).
Huguet et al., “Complete Amino Acid Sequence if the B-Chain of Mistletoe Lectin I”,Biochemical and Biophysical Research Communications, (246:3)596-601(1998).
Grabherr et al.,Biotechnics, (22)730-735(1997).
Joelson et al.,Journal of General Virology, (78)1213-1217(1997).
Kayser et al.,Tumordiag.und Ther., (13)190-195(1992).
Kumagai et al.,Proc. Natl. Acad. Sci. USA, (90)427-430(1993).
Luther et al.,Int. J. Biochem., (11)429-435(1980).
Macindoe et al.,Carbohydrate Research, (269:2)227-257(1995).
Meynial-Salles et al.,J. Biotechnol., 46(1)1-14(1996).
Miller et al.,Human Gene Therapy, (8)803-815(1997).
Nickrent et al.,American Journal of Botany, (81)1149-1160(1994).
Niwa H. et al., Crystal structure at 3A of mistletoe lectin I, a dimeric type-II ribosome-inactivating protein, complexed with galactose. Eur. J. Biochem. vol. 270, pp. 2739-2749 (2003).
Paprocka et al., “The Activity if Two Immunotoxins Composed of Monoclonal Antibody MOAB-16 and A-Chain of Ricin(MOAB-16-MLIA) or A-Chain of Mistletoe Lectini(MOAB-16-MLIA)”,Archivum Immunologiae et Therapiae Experimentalis, 40(3)223-227(1992).
Schink et al.,Naturwissenschaften, (79)80-81(1992).
Storm et al.,Hybridoma, (16)119-125(1997).
Sweeney, E.C. et al., Crystallization of the ribosome inactivating protein ML1 from Viscum album (mistletoe) complexed with beta-D-galactose. J. Mol. Biol. vol. 234, pp. 1279-1281 (1993).
Thierry et al.,Gene Therapy, (4)226-237(1997).
Walter et al.,Molecular Biotechnology, (6)267-286(1996).
Wong, S. Y.,Current Opinion in Structural Biology, 5(5)599-604(1995).
Morris Peter
Stiefel Thomas
Voelter Wolfgang
Welters Peter
Biosyn Arzeimittel GmbH
Carlson Karen Cochrane
Noakes Suzanne M.
LandOfFree
Recombinant mistletoe lectin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant mistletoe lectin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant mistletoe lectin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3747722